게놈 암 검사 시장 : 검사 유형별, 암 유형별, 기술별, 최종사용자별, 바이오마커 유형별, 서비스 제공업체별, 용도별, 검사 환경별, 지역별
Genomic Cancer Testing Market, By Test Type, By Cancer Type, By Technology, By End-User, By Biomarker Type, By Service Provider, By Application, By Testing Setting, By Geography
상품코드:1741184
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
게놈 암 검사 시장은 2025년 220억 달러, 2032년에는 648억 5,000만 달러에 이를 것으로 예측되며, 2025-2032년 16.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
보고서 범위
보고서 상세
기준 연도
2024년
2025년 시장 규모
220억 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간(2025-2032년) CAGR
16.70%
2032년 가치 예측
648억 5,000만 달러
게놈 암 검사는 종양학 분야를 빠르게 변화시키고 있습니다. 이 검사는 암세포의 유전자 구성을 분석하여 환자의 질병을 유발하는 돌연변이에 대한 통찰력을 제공합니다. 이러한 개별화 접근법을 통해 임상의는 개인의 유전자 프로파일에 따라 치료를 조정하고 존재하는 이상을 직접 표적으로 삼는 치료제를 선택할 수 있습니다. 종양 유전체 분석은 특정 약물에 대한 반응을 예측하고, 재발 위험이 높음을 나타내는 유전자 마커를 확인하고, 암 성장을 막기 위해 차단할 수 있는 생물학적 경로를 식별하는 데 도움이 됩니다. 유전체 기술의 지속적인 발전으로 암 검사가 더욱 종합적이고 저렴해지고 있습니다. 이는 향후 몇년안에 많은 암 환자들의 예후를 크게 개선할 수 있을 것으로 기대됩니다.
시장 역학:
세계 게놈 암 검사 시장은 주로 전 세계 암 발병률 증가와 이에 따른 정밀의료 접근법에 대한 수요에 의해 주도되고 있습니다. 바이오마커 식별을 위한 차세대 염기서열 분석(NGS) 기술의 적용이 확대되고 있는 것도 시장 성장을 견인하고 있습니다. 그러나 특히 개발도상국에서는 유전체 분석에 필요한 인프라와 숙련된 전문가 부족이 큰 문제점으로 지적되고 있습니다. 검사 절차의 높은 비용도 보급을 더욱 제한하고 있습니다. 그러나 새로운 진단 도구를 개발하기 위한 민간 및 공공 기관의 자금 지원은 유리한 기회를 제공합니다. 진단 기업과 암센터와의 파트너십은 유전체 프로파일링에 대한 접근성을 확대하는 것을 목표로 하고 있습니다. 실용적인 유전체 변화를 감지하고 동반 진단 약물을 검증하기 위한 기타 전략적 이니셔티브는 게놈 암 검사 시장을 더욱 자극할 것입니다. 또한, 시장 참여자들 간의 협력 관계 강화는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2023년 4월, 인공지능 및 정밀의료 분야의 선도기업인 Tempus는 진행성 또는 전이성 갑상선 수질암(MTC) 또는 진행성 또는 전이성 비갑상선 수질암(비 MTC)을 가진 적격 환자에게 유전체 검사에 대한 접근성을 확대하기 위해 설계된 Eli Lilly and Company가 후원하는 새로운 제휴를 오늘 발표했습니다. 이번 협력은 템포스가 분자 프로파일링을 무료로 제공하고, 의사들과 협력하여 광범위한 유전체 검사를 통해 환자들에게 데이터에 기반한 치료법을 제공할 수 있도록 지원하는 것입니다.
본 조사의 주요 특징
이 보고서는 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모와 연평균 성장률(CAGR%)을 분석하여 세계 게놈 암 검사 시장을 상세하게 연구한 보고서입니다.
또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 게놈 암 검사 시장의 주요 기업을 프로파일링합니다.
이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
세계 게놈 암 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 게놈 암 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
영향 분석
주요 하이라이트
규제 시나리오
제품 발매 및 승인
PEST 분석
PORTER 분석
인수합병(M&A) 시나리오
제4장 세계의 게놈 암 검사 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측 분석
경제에 대한 영향
제5장 세계의 게놈 암 검사 시장, 검사 유형별, 2020년-2032년
유전체 프로파일링 검사
액체생검 검사
동반진단 검사
약물유전체학 검사
유전성 암 검사
기타 전문적인 유전체 검사
제6장 세계의 게놈 암 검사 시장, 암 유형별, 2020년-2032년
유방암
폐암
대장암
전립선암
난소암
흑색종
백혈병
림프종
기타 특정 암 유형
제7장 세계의 게놈 암 검사 시장, 기술별, 2020년-2032년
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)
Fluorescence In Situ Hybridization (FISH)
마이크로어레이
면역조직화학(IHC)
기타 유전체 검사 기술
제8장 세계의 게놈 암 검사 시장, 최종사용자별, 2020년-2032년
병원
진단실험실
학술연구기관
암센터
기타 의료 제공자
제9장 세계의 게놈 암 검사 시장, 바이오마커 유형별, 2020년-2032년
유전자 바이오마커
단백질 바이오마커
분자 바이오마커
에피제네틱 바이오마카
제10장 세계의 게놈 암 검사 시장, 서비스 제공업체별, 2020년-2032년
진단실험실
바이오테크놀러지 기업
제약회사
계약연구기관(CRO)
제11장 세계의 게놈 암 검사 시장, 지역별, 2020년-2032년
북미
미국
캐나다
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
유럽
영국
독일
이탈리아
프랑스
스페인
러시아
기타 유럽
아시아태평양
중국
인도
일본
ASEAN
호주
한국
기타 아시아태평양
중동
GCC
이스라엘
기타 중동
아프리카
북아프리카
중앙아프리카
남아프리카
제12장 경쟁 구도
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Qiagen N.V.
F.Hoffmann-La Roche Ltd.
Foundation Medicine, Inc.(Roche)
Invitae Corporation
NeoGenomics Laboratories, Inc.
Myriad Genetics, Inc.
Genomic Health, Inc.(Exact Sciences Corporation)
Caris Life Sciences
ArcherDX, Inc.(Invitae Corporation)
Guardant Health, Inc.
Personal Genome Diagnostics Inc.
Biocept, Inc.
Tempus Labs, Inc.
제13장 섹션
조사 방법
출판사에 대해
LSH
영문 목차
영문목차
Genomic Cancer Testing Market is estimated to be valued at USD 22.00 Bn in 2025 and is expected to reach USD 64.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.7% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 22.00 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
16.70%
2032 Value Projection:
USD 64.85 Bn
Genomic cancer testing is rapidly transforming the field of oncology. It involves analyzing the genetic makeup of cancer cells to gain insights into the mutations driving a patient's disease. This personalized approach enables clinicians to tailor treatment based on an individual's genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may indicate higher risk of recurrence, and pinpoints biological pathways that can be blocked to stop cancer growth. With continued advances in genomic technologies, cancer testing is becoming more comprehensive and affordable. This is expected to significantly improve outcomes for many cancer patients in the coming years.
Market Dynamics:
The global genomic cancer testing market is primarily driven by rising cancer burden worldwide and subsequent demand for precision medicine approaches. Growing application of next-generation sequencing (NGS) technologies for biomarker identification is also fueling market growth. However, lack of infrastructure and skilled professionals required for genomic analysis poses a major challenge, especially in developing nations. High cost of testing procedures further limits widespread adoption. Yet funding from private and public bodies to develop novel diagnostic tools presents lucrative opportunities. Partnerships between diagnostic companies and cancer centers aim to expand access to genomic profiling. Other strategic initiatives to detect actionable genomic alterations and validate companion diagnostics will further stimulate the genomic cancer testing market. MOrevoer, increasing collaboration between market players is expected to drive the market growth over forecast period. For instance, in April 2023, Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed to expand access to genomic testing for eligible patients who have advanced or metastatic medullary thyroid cancer (MTC) OR advanced or metastatic non-medullary thyroid cancer (non-MTC). This collaboration offers Tempus' molecular profiling offerings at no cost while simultaneously working with physicians to support them in providing data-driven treatment to their patients with the use of broad-panel genomic testing.
Key features of the study:
This report provides in-depth analysis of the global genomic cancer testing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global genomic cancer testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc. (Roche), Invitae Corporation, NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc. (Exact Sciences Corporation), Caris Life Sciences, ArcherDX, Inc. (Invitae Corporation), Guardant Health, Inc., Personal Genome Diagnostics Inc., Biocept, Inc., and Tempus Labs, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global genomic cancer testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genomic cancer testing market
Detailed Segmentation:
Global Genomic Cancer Testing Market, By Test Type:
Genomic Profiling Tests
Liquid Biopsy Tests
Companion Diagnostic Tests
Pharmacogenomic Tests
Hereditary Cancer Tests
Other specialized genomic tests
Global Genomic Cancer Testing Market, By Cancer Type:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Melanoma
Leukemia
Lymphoma
Other specific cancer types
Global Genomic Cancer Testing Market, By Technology:
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence In Situ Hybridization (FISH)
Microarray
Immunohistochemistry (IHC)
Other genomic testing technologies
Global Genomic Cancer Testing Market, By End User:
Hospitals
Diagnostic Laboratories
Academic and Research Institutions
Cancer Centers
Other healthcare providers
Global Genomic Cancer Testing Market, By Biomarker Type:
Genetic Biomarkers
Protein Biomarkers
Molecular Biomarkers
Epigenetic Biomarkers
Global Genomic Cancer Testing Market, By Service Provider:
Diagnostic Laboratories
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations (CROs)
Global Genomic Cancer Testing Market, By Application:
Targeted Therapy Selection
Disease Monitoring
Prognostic Testing
Companion Diagnostics
Risk Assessment
Pharmacogenomic Testing
Global Genomic Cancer Testing Market, By Testing Setting:
In-House Testing
Outsourced Testing
Global Genomic Cancer Testing Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
Foundation Medicine, Inc. (Roche)
Invitae Corporation
NeoGenomics Laboratories, Inc.
Myriad Genetics, Inc.
Genomic Health, Inc. (Exact Sciences Corporation)
Caris Life Sciences
ArcherDX, Inc. (Invitae Corporation)
Guardant Health, Inc.
Personal Genome Diagnostics Inc.
Biocept, Inc.
Tempus Labs, Inc.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Genomic Cancer Testing, By Test Type
Market Genomic Cancer Testing, By Cancer Type
Market Genomic Cancer Testing, By Technology
Market Genomic Cancer Testing, By End User
Market Genomic Cancer Testing, By Biomarker Type
Market Genomic Cancer Testing, By Service Provider
Market Genomic Cancer Testing, By Application
Market Genomic Cancer Testing, By Testing Setting
Market Genomic Cancer Testing, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing Cancer Incidence
High Costs
Increasing Cancer Incidence
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Global Genomic Cancer Testing Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Genomic Cancer Testing Market, By Test Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Genomic Profiling Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Liquid Biopsy Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Companion Diagnostic Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pharmacogenomic Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hereditary Cancer Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other specialized genomic tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Genomic Cancer Testing Market, By Cancer Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ovarian Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Melanoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other specific cancer types
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Genomic Cancer Testing Market, By Technology, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Next-Generation Sequencing (NGS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Polymerase Chain Reaction (PCR)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Fluorescence In Situ Hybridization (FISH)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Microarray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Immunohistochemistry (IHC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other genomic testing technologies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Genomic Cancer Testing Market, By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Academic and Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cancer Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other healthcare providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Genomic Cancer Testing Market, By Biomarker Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Genetic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Molecular Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Epigenetic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Global Genomic Cancer Testing Market, By Service Provider, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021- 2032
Segment Trends
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations (CROs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
11. Global Genomic Cancer Testing Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021-2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country , 2020-2032,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Testing Setting, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2020-2032,(US$ Bn)
